Reduced circulating miR-15b is correlated with phosphate metabolism in patients with end-stage renal disease on maintenance hemodialysis

Renal Failure

Volumn 34, Issue 6, 2012, Pages 685-690

  Wang, Honglei ^a   Peng, Wujian ^a   Ouyang, Xin ^a   Dai, Yong ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

end stage renal disease; hemodialysis; microRNAs; miR 15b; phosphate

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIUM; HEMOGLOBIN; MICRORNA 15B; PHOSPHATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DNA MODIFICATION; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAINTENANCE THERAPY; MALE; PATHOGENESIS; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MICRORNAS; MIDDLE AGED; PHOSPHATES; REAL-TIME POLYMERASE CHAIN REACTION; RENAL DIALYSIS;

EID: 84862168983     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.676491     Document Type: Article

References (30)

1. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 2004;116:281-297.
2. Kato M, Arce L, Natarajan R. MicroRNAs and their role in progressive kidney diseases. Clin J Am Soc Nephrol. 2009; 4:1255-1266.
3. Sequeira Lopez ML, Gomez RA. Novel mechanisms for the control of renin synthesis and release. Curr Hypertens Rep. 2010;12:26-32.
4. Li JY, Yong TY, Michael MZ, Gleadle JM. Review: The role of microRNAs in kidney disease. Nephrology (Carlton). 2010;15:599-608.
5. Dai Y, Sui W, Lan H, Yan Q, Huang H, Huang Y. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int. 2009;29:749-754.
6. Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA. 2011;108:5003-5008.
7. Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, Liu S. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One. 2010;5:e13735.
8. Fichtlscherer S, De Rosa S, Fox H, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010;107:677-684.
9. Tijsen AJ, Creemers EE, Moerland PD, et al. MiR423-5p as a circulating biomarker for heart failure. Circ Res. 2010;106: 1035-1039.
10. Lorenzo Sellares V, Torregrosa V. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Nefrologia. 2008;28(Suppl 3):67-78.
11. Goettsch C, Rauner M, Pacyna N, Hempel U, Bornstein SR, Hofbauer LC. miR-125b regulates calcification of vascular smooth muscle cells. Am J Pathol. 2011;179:1594-1600.
12. Boucher JM, Peterson SM, Urs S, Zhang C, Liaw L. The miR-143/145 cluster is a novel transcriptional target of Jagged-1/ Notch signaling in vascular smooth muscle cells. J Biol Chem. 2011;286:28312-28321.
13. Finnerty JR, Wang WX, Hebert SS, Wilfred BR, Mao G, Nelson PT. The miR-15/107 group of microRNA genes: Evolutionary biology, cellular functions, and roles in human diseases. J Mol Biol. 2010;402:491-509.
14. Gao J, Yang T, Han J, et al. MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow. J Cell Biochem. 2011;112:1844-1856.
15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) method. Methods. 2001;25:402-408. (Pubitemid 34164012)
16. Neal CS, Michael MZ, Pimlott LK, Yong TY, Li JY, Gleadle JM. Circulating microRNA expression is reduced in chronic kidney disease. Nephrol Dial Transplant. 2011;26:3794-3802.
17. Floege J, Kim J, Ireland E, et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European hemodialysis population. Nephrol Dial Transplant. 2011;26:1948-1955.
18. Kendrick J, Chonchol M. The role of phosphorus in the development and progression of vascular calcification. Am J Kidney Dis. 2011;58:826-834.
19. Ossareh S. Vascular calcification in chronic kidney disease: Mechanisms and clinical implications. Iran J Kidney Dis. 2011;5:285-299.
20. Arcidiacono T, Paloschi V, Rainone F, et al. Renal osteodystrophy and vascular calcification. J Endocrinol Invest. 2009; 32:21-26.
21. Gattineni J, Baum M. Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): Implications for disorders of phosphate metabolism. Pediatr Nephrol. 2010; 25:591-601.
22. Gupta D, Brietzke S, Hayden MR, Kurukulasuriya LR, Sowers JR. Phosphate metabolism in cardiorenal metabolic disease. Cardiorenal Med. 2011;1:261-270.
23. Nakai K, Komaba H, Fukagawa M. New insights into the role of fibroblast growth factor 23 in chronic kidney disease. J Nephrol. 2010;23:619-625.
24. Tesse A, Martinez MC, Meziani F, et al. Origin and biological significance of shed-membrane microparticles. Endocr Metab Immune Disord Drug Targets. 2006;6:287-294. (Pubitemid 44383212)
25. Zampetaki A, Kiechl S, Drozdov I, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010;107:810-817.
26. Valdivielso JM. [Vascular calcification: Types and mechanisms]. Nefrologia. 2011;31:142-147.
27. Kockx MM, De Meyer GR, Muhring J, Jacob W, Bult H, Herman AG. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation. 1998;97:2307-2315. (Pubitemid 28280384)
28. Yue J, Tigyi G. Conservation of miR-15a/16-1 and miR-15b/16-2 clusters. Mamm Genome. 2010;21:88-94.
29. Guo CJ, Pan Q, Li DG, Sun H, Liu BW. miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis. J Hepatol. 2009;50:766-778.
30. Prokopi M, Pula G, Mayr U, et al. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood. 2009;114:723-732.